Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
about
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitroNovel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolatesPharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.Foscarnet for suppression of human immunodeficiency virus replication.Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet.Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDSAge-related differences in pharmacokinetics of phosphonoformate in cats.Antiretroviral therapy: reverse transcriptase inhibition.Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.Antiviral therapy: current concepts and practicesAntineurofilament and antiretinal antibodies in AIDS patients with cytomegalovirus retinitis.Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection."The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.
P2860
Q28342758-5A81EB1B-A4DF-4AF9-92CA-D6680B833A29Q28367722-776333C9-96AF-4285-AB24-3F4F893CF735Q33377921-031BAC64-6883-40A3-B9B3-26D95E7931A9Q33751608-59C5729F-E373-49C4-A604-B9BE73677123Q35118174-86F08B87-293D-43E0-AE36-85557A5C26F1Q35129803-90FB9C0F-12C9-4A1A-955D-093D45FB8220Q35254452-353E6DDA-34ED-43E8-8972-08F433C20358Q35322871-3F08006F-03F8-4C79-BEE6-74E82C1944E0Q35333643-8699CB3F-89A6-4D67-84BD-1A6214276903Q35870930-A54E2D07-C456-48D8-81FB-1F25804CCC5CQ35894405-FE0E5702-BA16-4184-90D8-C4E37381A164Q35896783-428E9357-E0C0-4707-B36B-DD54C46101E1Q36070394-AD4091FD-7FCB-4164-9B78-E14D17EF22A3Q36929871-B7102498-9A99-410C-BED2-A475369A220DQ39833019-46653FFD-4384-40F6-B80B-8A60AB172CB0Q40720231-1DBFD91F-652C-481A-9D0D-2A9DC135CF0D
P2860
Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@en
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@nl
type
label
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@en
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@nl
prefLabel
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@en
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@nl
P2093
P1476
Effect of Foscarnet therapy on ...... y virus in patients with AIDS.
@en
P2093
Gambertoglio J
Jacobson MA
P304
P407
P577
1988-10-01T00:00:00Z